Patrick John Finn, President and COO at Twist Bioscience Corp (TWST), sold 78,355 shares at $115.90 ($9.2M) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Scheduled sale ($9.2M) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.90 | 33,354 | $3.9M | 41.9% |
| 2 | $116.82 | 10,420 | $1.2M | 13.2% |
| 3 | $117.70 | 8,868 | $1.0M | 11.3% |
| 4 | $119.04 | 4,500 | $536K | 5.8% |
| 5 | $119.86 | 12,917 | $1.5M | 16.8% |
| 6 | $121.01 | 6,296 |
| $762K |
| 8.3% |
| 7 | $122.58 | 2,000 | $245K | 2.7% |
| Total | $117.64 avg | 78,355 | $9.2M | 100% |
| Filing → |
| TWST | SELL | 2026-08-05 | $246K | — | Filing → |
| TWST | SELL | 2026-07-27 | $210K | — | Filing → |
| TWST | SELL | 2026-05-26 | $222K | — | Filing → |